
Myeloma Paper of the Day, August 31st, Suggested by Robert Orlowski
Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Study of HSC mobilization with G-CSF +/- cyclo before ASCT in NDMM receiving induction +/- daratumumab notes D-VRd patients, especially when mobilized with G-CSF only, had higher failure rates and increased plerixafor use.”
Title: Mobilization of hematopoietic stem cells using G-CSF with or without cyclophosphamide before autologous stem cell transplantation in patients with newly diagnosed multiple myeloma receiving induction therapy with or without daratumumab
Authors: Cathelijne Fokkema, Marjolein K. Appelman, Niels Veldhoen, Annie Spelt, Bronno van der Holt, Meriam Grootes, Ruth Wester, Emma de Pater, Paula F. Ypma, Annoek E. C. Broers, Pieter Sonneveld, Annemiek Broijl
You can read the Full Article in Bone Marrow Transplantation.
You can find more posts featuring Robert Orlowski on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023